Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Debt to Equity: 2010-2025

Historic Debt to Equity for UNITED THERAPEUTICS (UTHR) over the last 11 years, with Mar 2025 value amounting to $0.03.

  • UNITED THERAPEUTICS's Debt to Equity fell 73.86% to $0.03 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.21, marking a year-over-year decrease of 62.14%. This contributed to the annual value of $0.05 for FY2024, which is 60.20% down from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Debt to Equity stood at $0.03 for Q1 2025, which was down 36.89% from $0.05 recorded in Q4 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Debt to Equity peaked at $0.23 during Q1 2021, and registered a low of $0.03 during Q1 2025.
  • In the last 3 years, UNITED THERAPEUTICS's Debt to Equity had a median value of $0.11 in 2024 and averaged $0.10.
  • Data for UNITED THERAPEUTICS's Debt to Equity shows a maximum YoY tumbled of 73.86% (in 2025) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Debt to Equity (Quarterly) stood at $0.20 in 2021, then dropped by 17.47% to $0.17 in 2022, then declined by 29.87% to $0.12 in 2023, then tumbled by 60.20% to $0.05 in 2024, then plummeted by 73.86% to $0.03 in 2025.
  • Its Debt to Equity stands at $0.03 for Q1 2025, versus $0.05 for Q4 2024 and $0.07 for Q3 2024.